ArticleQuantitative biology (Beijing, China)2026
MFCN-DDI: Capsule network based on multimodal feature for multitype drug-drug interaction prediction.
Article in Quantitative biology (Beijing, China), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- MFCN-DDI: Capsule network based on multimodal feature for multitype drug-drug interaction prediction.Quantitative biology (Beijing, China) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Precise prediction of drug-drug interactions (DDIs) is essential for pharmaceutical research and clinical applications to minimize adverse reactions, optimize therapies, and reduce costs. However, existing methods still face challenges in effectively integrating multidimensional drug features and fully utilizing edge features in molecular graphs, which are crucial for predicting DDIs precisely. Moreover, current methods may not adequately capture the complex relationships between different types of features, limiting predictive performance. This paper proposes the MFCN-DDI model for DDI type prediction. The model consists of a multimodal feature extraction module, a capsule network-based feature fusion module, and a DDI predictor module. In the multimodal feature extraction module, four kinds of features are used to provide rich and comprehensive representations for subsequent DDI type prediction, where molecular graph features are generated by considering molecular graphs with edge features. The capsule network-based feature fusion module captures complex feature relationships to generate high-quality integrated representations. In the DDI predictor module, multiclass and multilabel classification predictions are performed accurately. Experimental results show that MFCN-DDI outperforms existing comparison models in prediction tasks. Case studies further prove its practical applicability. In summary, MFCN-DDI provides an efficient and reliable solution for DDI prediction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.